Ilaria Catalano

Chief Operating Officer at MSD Italia Srl

Health Technology

Profile

Ilaria Catalano has worked at MSD Italia Srl since 2008.
Her current job title is Executive Director-Business Operations, which she started in 2013.

Ilaria Catalano active positions

Companies	Position	Start
MSD Italia Srl MSD Italia Srl Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.	Chief Operating Officer	2012-12-31

All active positions of Ilaria Catalano

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ilaria Catalano's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
MSD Italia Srl MSD Italia Srl Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.	Health Technology